Cilostazol - BlackBoxRX.com

Cilostazol

Contraindicated for use in CHF patients

Cilostazol and several of its metabolites are inhibitors of phosphodiesterase III. Such activity has been shown to decrease survival compared to placebo in patients with class III-IV CHF.
Contraindicated in patients with CHF of any severity.

Patient Counseling Information

Cilostazol

Pletal

Package Inserts

Cilostazol

Updated August 2009

Disclaimer: This information presents a SUMMARY of Black Box data from product information labeling and does not address additional warnings, precautions, or other important safety data in the product insert. Patient care decisions SHOULD NOT be made without reviewing the most recent product information insert, which may be obtained from the manufacturer. This table may not be complete as it was prepared using product information from package inserts. It is periodically updated with supplemental information from FDA safety alerts, the FDA labeling announcements, and new drug approvals.

Formweb is a product of Formulary Productions, LLC. Visit our website at www.formweb.com for more information on online formularies featuring Black Box Warnings.
901-767-3000